Track record · closed signal

Eli Lilly and Company (LLY) — closed signal from May 25, 2026

Target reached Published before the outcome was known, scored automatically when the window closed on August 23, 2026.

Predicted vs. what happened

LLY price · publication thesis → realized outcomesplit-adjusted
$1,065.00 Published $1,214.10 Target $1,255.40 Window close $1,292.65 Peak
$1,020.00 – $1,060.00Entry zone — fair-value band
$1,065.00Published — price the day we called it
$1,214.10Target — the price the thesis aimed for
$1,292.65Peak — highest point inside the window, not a realized return
$1,255.40Window close — end-of-window price, context only

What happened

Target reached

Reached its target in 32 days.

Peak price
$1,292.65
peak on August 19, 2026 — not a realized return
Peak gain
+21.4%
peak, from the publication price
Window close
$1,255.40
end-of-window price, context only
Days to target
32
Window
May 25, 2026 – August 23, 2026

The thesis — published May 25, 2026

Predicted growth
+14%
over the measurement window
Target price
$1,214.10
the price the thesis aimed for
Entry zone
$1,020.00 – $1,060.00
the fair-value band we waited for
Price at publication
$1,065.00
published May 25, 2026
Confidence
80%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

Eli Lilly stands out as a large pharmaceutical company with fast growth driven by obesity, diabetes and cardiometabolic drugs. Recent positive updates on retatrutide and VERVE-102 give near-term reasons for interest. The stock ran up quickly and could be volatile soon, but strong earnings, a deep drug pipeline and defensive healthcare exposure support a constructive short-term setup if price calms.

Primary drivers

  • Positive retatrutide results strengthen the weight-loss drug program
  • VERVE-102 news adds optional benefits for cardiometabolic treatment
  • Leading diabetes and obesity products create steady demand
  • Healthcare sector exposure provides defensive qualities

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All LLY signals